United States HR 4278: To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.

Status: Referred to the Subcommittee on Health. (as of 2021-07-01)

State: United States · Session: 117 · Bill: HR 4278

Sponsors: Gregory Murphy, Diana Harshbarger

View United States HR 4278 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.